Ajanta Pharma has launched acid reflux drug in US
Ajanta Pharma has launched generic omeprazole and sodium bicarbonate capsules that are used in the treatment acid reflux and uclers, in the US market after...
Tag : US
Ajanta Pharma has launched anti-dementia drug in US
Ajanta Pharma has launched anti-dementia Memantine Hydrochloride tablets in the US market. The company has announced in BSE filing ” the launch of Memantine Hydrochloride...
Dr Reddy’s Labs signs agreement to buy eight ANDAs in US for $350 mn
An agreement has been signed by Dr Reddy’s Laboratories with Teva Pharmaceutical and an affiliate of Allergan PIc for buying a portfolio of eight abbreviated...
Lupin aims 25-30 product launches in US this fiscal
Lupin is aiming to launch up to 30 drugs in the US market in the current fiscal, whereas it has been awaiting approval of around...
Torrent Pharma has recalled 20,952 cartons of hypertension drug in US
Torrent Pharma which is based at Ahmedabad has been recalling 20,952 cartons of Telmisartan tablets that are used in the treatment of hypertension in US...
Lupin has launched generic insomnia drug in US
A generic insomnia drug, Zolpidem Sublingual tablets has been launche by the drug major Lupin in the US market with 180 days of marketing exclusivity....
ArcelorMittal aims to sell LaPlace and Vinton steel plants in US
ArcelorMittal, the largest steel manufacturer is going to sell its LaPlace and Vinton Long Carbon facilities in the US to an affiliate of the asset...
Infosys has cleared of visa violation charge by US Department of Labor
Infosys, the second largest software services firm of India said today that the US government has found no visa violations in a probe began in...
WTO has ruled out against India in solar dispute
According to a business newspaper, the World Trade Organisation (WTO) has ruled against India in a dispute with the United States on its solar power...
US has urged China to make its economy transparent
The White House has urged China, which is facing one of the worst financial crises in decades, to follow the financial reform and move quickly towards...